Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- B. Riley Securities analyst Drew Crum initiated coverage on Angel Studios Inc (NYSE:ANGX) with a Buy rating and announced a price target of $7. Angel Studios shares closed at $3.63 on Wednesday. See how other analysts view this stock.
- Stifel analyst Alex Thompson initiated coverage on Alumis Inc (NASDAQ:ALMS) with a Buy rating and announced a price target of $44. Alumis shares closed at $29.39 on Wednesday. See how other analysts view this stock.
- RBC Capital initiated coverage on Merck & Co Inc (NYSE:MRK) with an Outperform rating and announced a price target of $142. Merck shares closed at $122.46 on Wednesday. See how other analysts view this stock.
- UBS analyst Natalia Winkler initiated coverage on Ceva Inc (NASDAQ:CEVA) with a Buy rating and announced a price target of $27. CEVA shares closed at $21.32 on Wednesday. See how other analysts view this stock.
- RBC Capital analyst Trung Huynh initiated coverage on Pfizer Inc (NYSE:PFE) with an Underperform rating and announced a price target of $25. Pfizer shares closed at $27.09 on Wednesday. See how other analysts view this stock.
Considering buying PFE stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments